Article
SWATH-MS for discovery of early biomarkers of drug-induced cardiotoxicity using an animal doxorubicin model
2025-08-19
Abstract excerpt
<title>Abstract</title> <p> <bold>Background</bold> Clinical use of anthracyclines is limited by cumulative dose-dependent cardiotoxicity, though the mechanisms responsible for this are complex and incompletely understood. Existing biomarkers of anthracycline-related cardiotoxicity, such as troponin and NT-proBNP, lack sensitivity for the earliest stages of cardiotoxicity, therefore limiting scope to switch to...
Topics
Open a Topic to create a Post that cites this publication.
- Cardiovascular Function and Risk Factors
- Chemotherapy-induced cardiotoxicity and mitigation
- Histone Deacetylase Inhibitors Research
- Metabolism, Diabetes, and Cancer
- Mitochondrial Function and Pathology
- Neuroblastoma Research and Treatments
- Pluripotent Stem Cells Research
- Sirtuins and Resveratrol in Medicine
Identifiers and source
- Literature Corpus work
- 1f7b8d5c-611b-561c-ac96-8af9632d5dbe
- DOI
- 10.21203/rs.3.rs-7251224/v1
